Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M

Authors :: Kang-Yi Su
Gee-Chen Chang
Kuo-Hsuan Hsu
Yen Hsiang Huang
Kun-Chieh Chen
Tsung-Ying Yang
Jeng-Sen Tseng
Jeremy J.W. Chen
Sung-Liang Yu
Source :: Scientific Reports, Vol 11, Iss 1, Pp 1-2 (2021)
Publication Year :: 2021
Publisher :: Nature Portfolio, 2021.

Subjects :: Oncology
medicine.medical_specialty
Multidisciplinary
business.industry
First line
Science
MEDLINE
Outcome (game theory)
T790M
Egfr tki
Internal medicine
Medicine
Osimertinib
business

Tools